(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.33%) $79.25
(-0.55%) $2.18
(-0.25%) $2 316.40
(-0.08%) $27.58
(0.08%) $985.40
(0.05%) $0.931
(0.10%) $10.90
(0.03%) $0.800
(0.01%) $91.75
5 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business...
Stats | |
---|---|
आज की मात्रा | 254 700 |
औसत मात्रा | 294 471 |
बाजार मूल्य | 301.49B |
EPS | ¥0 ( 2024-02-08 ) |
अगली कमाई की तारीख | ( ¥83.23 ) 2024-05-13 |
Last Dividend | ¥36.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 14.06 |
ATR14 | ¥2.06 (0.04%) |
मात्रा सहसंबंध
Suzuken Co., Ltd. सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Suzuken Co., Ltd. सहसंबंध - मुद्रा/वस्त्र
Suzuken Co., Ltd. वित्तीय
Annual | 2022 |
राजस्व: | ¥2 314.83B |
सकल लाभ: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
राजस्व: | ¥2 314.83B |
सकल लाभ: | ¥179.70B (7.76 %) |
EPS: | ¥236.46 |
FY | 2022 |
राजस्व: | ¥2 232.77B |
सकल लाभ: | ¥160.99B (7.21 %) |
EPS: | ¥163.19 |
FY | 2021 |
राजस्व: | ¥2 128.48B |
सकल लाभ: | ¥157.84B (7.42 %) |
EPS: | ¥88.52 |
Financial Reports:
No articles found.
Suzuken Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥36.00 (N/A) |
¥0 (N/A) |
¥36.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥9.09 | 2001-03-27 |
Last Dividend | ¥36.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥939.27 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.84 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 2.58 | |
Div. Directional Score | 4.59 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
7949.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7182.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6420.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
5401.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
4410.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3593.T | Ex Dividend Knight | 2023-09-28 | Quarterly | 0 | 0.00% | |
2811.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
1429.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9729.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8769.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0117 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0212 | 1.200 | 9.29 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0664 | 1.500 | -0.373 | -0.560 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.186 | 0.800 | 9.07 | 7.26 | [1 - 3] |
quickRatioTTM | 0.954 | 0.800 | 9.10 | 7.28 | [0.8 - 2.5] |
cashRatioTTM | 0.206 | 1.500 | 9.97 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 807.19 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.0775 | 1.000 | -2.04 | -2.04 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0146 | 1.000 | -1.707 | -1.707 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 1.818 | 0.800 | 1.213 | 0.970 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.84 | 1.000 | 8.70 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0664 | 2.50 | -0.240 | -0.560 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.692 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 212.65 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -3.58 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00727 | 1.000 | -2.32 | 0 | [0.1 - 0.5] |
Total Score | 2.58 |
Suzuken Co., Ltd.
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं